Tesamorelin
HIV 관련 지방이영양증에 대한 FDA 승인 GHRH 유사체
개요
Tesamorelin은 FDA 승인을 받은 GHRH 아날로그로, HIV 관련 지질이영양증(복부 지방 과다 축적) 치료에 특별히 사용하도록 승인되어 있습니다.
Key Information
Mechanism
내인성 GH 생성을 자극하고 내장 지방 감소를 표적으로 하는 안정화된 GHRH 유사체입니다.
Benefits
- FDA 승인
- 내장 지방 감소
- HIV 지방이영양증 표적
- 자연 성장호르몬(GH) 자극
Side Effects
- 주사 부위 반응
- 관절통
- 경미한 부종
Contraindications
- Active cancer
- Pregnancy
- Disruption of hypothalamic-pituitary axis
Evidence Summary
3상 임상시험에서 HIV 지방이영양증 환자의 내장 지방 조직 감소 효과가 입증되어 FDA 승인을 받았습니다.
Research
내장 지방 조직의 유의미한 감소를 보여준 3상 임상시험 결과를 바탕으로 FDA 승인을 받았습니다.
View ResearchSafety
FDA 승인. 부작용으로는 주사 부위 반응과 관절 통증이 있습니다.
Frequently Asked Questions About Tesamorelin
What is Tesamorelin?
Tesamorelin is a research peptide also known as Egrifta. HIV 관련 지방이영양증에 대한 FDA 승인 GHRH 유사체 It is studied for its potential therapeutic applications and is available from various research chemical vendors.
How does Tesamorelin work?
내인성 GH 생성을 자극하고 내장 지방 감소를 표적으로 하는 안정화된 GHRH 유사체입니다.
What is the recommended dosage for Tesamorelin?
The commonly studied dosage range for Tesamorelin is 2 mg daily. Dosage protocols vary based on research objectives. Always consult published studies and start with conservative amounts. Tesamorelin should only be used in controlled research settings.
Where can I buy Tesamorelin?
PepsReview indexes Tesamorelin pricing from multiple vendors. Check the Vendors tab above for a price comparison table showing cost per milligram, purity, COA status, and stock availability. Vendor reviews from real users are available on each vendor's profile page.
Is Tesamorelin legal?
US regulatory status: FDA-approved (Egrifta). The legal status of Tesamorelin varies by jurisdiction. In most countries, it is sold as a research chemical, not for human consumption. Always verify the legal status in your country before purchasing.
What are the side effects of Tesamorelin?
Reported side effects include: 주사 부위 반응, 관절통, 경미한 부종. Always review safety data and published studies before use.
Key Research Papers on Tesamorelin
The following peer-reviewed studies and clinical trials are indexed in our research library for Tesamorelin. Each paper links to a detailed summary with key findings, study design, and publication metadata.
- Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy — Drugs, 2011 (300 citations)
- Spotlight on tesamorelin in HIV-associated lipodystrophy — BioDrugs, 2011 (300 citations)
- Tesamorelin: a growth hormone-releasing factor analogue for HIV-associated lipodystrophy — Ann Pharmacother, 2012 (280 citations)
Related Growth hormone boosters Peptides
Other peptides in the growth hormone boosters category that may be of interest for comparative research:
Write a Review
Rating Breakdown
Based on 2 리뷰.
리뷰
Tesamorelin specifically targets visceral fat. Lost 3 inches off waist in 4 months. FDA-approved for HIV lipodystrophy but works for metabolic syndrome too. GH stimulation is natural and potent.
Tesamorelin works well for visceral fat reduction but the cost is very high. Better results than CJC-1295 for abdominal fat. If you can afford it and have stubborn visceral fat, this is the peptide.